Association of Multidrug Resistance Bacteria and Clinical Outcomes of Adult Patients with Sepsis in the Intensive Care Unit
- PMID: 36355907
- PMCID: PMC9692934
- DOI: 10.3390/tropicalmed7110365
Association of Multidrug Resistance Bacteria and Clinical Outcomes of Adult Patients with Sepsis in the Intensive Care Unit
Abstract
Background: Multi-drug resistance organisms (MDRO) often cause increased morbidity, mortality, and length of stays (LOS). However, there is uncertainty whether the infection of MDRO increase the morbidity, mortality, and ICU-LOS. Objective: This study was performed to determine the prevalence of MDRO in the ICU, the site of infection, and the association of MDRO or site of infection with mortality. The secondary outcome was determined by ascertaining the association of MDRO or site of infection with ICU-LOS. Methods: A retrospective cohort study was performed with adult sepsis patients in the ICU. Univariate and multivariate (MVA) logistic regression with cox regression modeling were performed to compute the association of MDRO with ICU mortality. MVA modelling was performed for ICU-LOS predictors. Results: Out of 228 patients, the isolated MDRO was 97 (42.5%), of which 78% were Gram-negative bacteria. The mortality rate among those with MDRO was 85 (37.3%). The hospital acquired infection (HAI) was a significant predictor for ICU-LOS in univariate linear regression (R2 = 0.034, p = 0.005). In MVA linear regression, both Enterococcus faecalis infection and Acinetobacter baumannii (AC)-MDRO were predictors for ICU-LOS with (R2 = 0.478, p < 0.05). In the univariate cox regression, only the infection with AC-MDRO was a risk factor for ICU-mortality with [HR = 1.802 (95% CI: 1.2−2.706; p = 0.005)]. Conclusions: Identifying risk factors for MDRO addresses the appropriate administration of empirical antibiotics and allows to effectively control the source of infection, which would reduce mortality and ICU-LOS. The usage of broad-spectrum antibiotics should be limited to those with substantial risk factors for acquiring MDRO.
Keywords: APACHE II; ICU length of stay; adequate empirical antibiotics; mortality; multidrug resistance organism; predictors; risk factors; sepsis; source of infection.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Appropriateness of empirical antibiotics: risk factors of adult patients with sepsis in the ICU.Int J Clin Pharm. 2020 Apr;42(2):527-538. doi: 10.1007/s11096-020-01005-4. Epub 2020 Mar 6. Int J Clin Pharm. 2020. PMID: 32144611
-
Multidrug-resistant bacterial infection in adult patients following cardiac surgery: clinical characteristics and risk factors.BMC Cardiovasc Disord. 2023 Sep 21;23(1):472. doi: 10.1186/s12872-023-03488-1. BMC Cardiovasc Disord. 2023. PMID: 37735348 Free PMC article.
-
Multi-drug resistant organism infections in a medical ICU: Association to clinical features and impact upon outcome.Med Intensiva (Engl Ed). 2018 May;42(4):225-234. doi: 10.1016/j.medin.2017.07.006. Epub 2017 Oct 13. Med Intensiva (Engl Ed). 2018. PMID: 29033075 English, Spanish.
-
Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms.J Infect. 2015 Mar;70(3):213-22. doi: 10.1016/j.jinf.2014.10.004. Epub 2014 Oct 27. J Infect. 2015. PMID: 25445887
-
Prevalence and Outcomes of Multi-Drug Resistant Blood Stream Infections Among Nursing Home Residents Admitted to an Acute Care Hospital.J Intensive Care Med. 2022 Apr;37(4):565-571. doi: 10.1177/08850666211014450. Epub 2021 May 3. J Intensive Care Med. 2022. PMID: 33938320
Cited by
-
Machine Learning-Based Prediction Model for Multidrug-Resistant Organisms Infections: Performance Evaluation and Interpretability Analysis.Infect Drug Resist. 2025 May 6;18:2255-2269. doi: 10.2147/IDR.S459830. eCollection 2025. Infect Drug Resist. 2025. PMID: 40353201 Free PMC article.
-
The Impact of Clinical Pharmacist Consultation on the Treatment of Multi-Drug Resistant Organisms (MDRO) Infections: A Retrospective Observational Study.J Multidiscip Healthc. 2025 May 28;18:2983-2995. doi: 10.2147/JMDH.S505931. eCollection 2025. J Multidiscip Healthc. 2025. PMID: 40458234 Free PMC article.
-
Factors associated with multidrug-resistant organism (MDRO) mortality: an analysis from the national surveillance of multidrug-resistant organism, 2018-2022.BMC Infect Dis. 2025 Jan 14;25(1):60. doi: 10.1186/s12879-024-10338-8. BMC Infect Dis. 2025. PMID: 39810126 Free PMC article.
-
Prevalence of Multidrug-Resistant Pathogens Causing Neonatal Early and Late Onset Sepsis, a Retrospective Study from the Tertiary Referral Children's Hospital.Infect Drug Resist. 2023 Jun 29;16:4213-4225. doi: 10.2147/IDR.S416020. eCollection 2023. Infect Drug Resist. 2023. PMID: 37404253 Free PMC article.
-
Infection Prevention and Control Strategies According to the Type of Multidrug-Resistant Bacteria and Candida auris in Intensive Care Units: A Pragmatic Resume including Pathogens R0 and a Cost-Effectiveness Analysis.Antibiotics (Basel). 2024 Aug 22;13(8):789. doi: 10.3390/antibiotics13080789. Antibiotics (Basel). 2024. PMID: 39200090 Free PMC article. Review.
References
-
- Busani S., Serafini G., Mantovani E., Venturelli C., Giannella M., Viale P., Mussini C., Cossarizza A., Girardis M. Mortality in Patients with Septic Shock by Multidrug Resistant Bacteria: Risk Factors and Impact of Sepsis Treatments. J. Intensive Care Med. 2017;34:48–54. doi: 10.1177/0885066616688165. - DOI - PubMed
-
- McConville T.H., Sullivan S.B., Gomez-Simmonds A., Whittier S., Uhlemann A.C. Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study. PLoS ONE. 2017;12:e0186195. doi: 10.1371/journal.pone.0186195. - DOI - PMC - PubMed
-
- Dat V.Q., Vu H.N., Nguyen H.T., Hoang L.B., Vu Tien Viet D., Bui C.L., Van Nguyen K., Nguyen T.V., Trinh D.T., Torre A., et al. Bacterial bloodstream infections in a tertiary infectious diseases hospital in Northern Vietnam: Aetiology, drug resistance, and treatment outcome. BMC Infect. Dis. 2017;17:493. doi: 10.1186/s12879-017-2582-7. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources